Absci Corporation

NASDAQ:ABSI

Biotechnology

Healthcare
$8.18 +1.04%

+$0.08 today

Market cap
$1.41B
Beta
2.46
P/E (TTM)
-9.4
EPS (TTM)
-$0.77
52W Low $2.24High $8.17

Volume 5.66M

Average 5.10M

ABSI Pre-Tax Margin

Income before tax as a percentage of revenue.

Absci CorporationNASDAQ: ABSI

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -13758.6%

Pre-tax margin was -13758.6% in Q1 FY2026, down 11523.7 pp from a year earlier. On a trailing-twelve-month basis it was -6445.8%, down 4214.8 pp year over year. Over 3 fiscal years it narrowed by 2277.8 pp.

Context

  • Pre-tax margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-13758.6%-9185.7 pp QoQ
Last fiscal yearDec 2025
-4111.2%-1838.7 pp YoY
LTMMar 2026
-6445.8%-4214.8 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-11523.7 pp——
1 year-1838.7 pp——
3 years-2277.8 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-4111.2%
Year-over-year change
-1838.7pp

Pre-Tax Margin vs competitors

How ABSI compares with its peers on the latest reported figures

  • ABSI's LTM Mar 2026 pre-tax margin of -6445.8% is the lowest of the 3 companies compared; the peer median is -475.2%.
  • Its year-over-year change of -4214.8 pp is the lowest of 3, against a peer median of +257.7 pp.
  • Over three fiscal years its change of -2277.8 pp compares with a peer median of -285.6 pp.
ABSI Competitors Peer median
Pre-Tax Margin for ABSI and competitors
Company Period LTM level YoY 3-year change
ABCLAbCellera Biologics Inc.LTM Sep 2026-251.7% +328.4 pp-285.6 pp
GENBGenerate Biomedicines, Inc.FY2025-698.6% +186.9 pp—
ABSIAbsci CorporationLTM Mar 2026-6445.8% -4214.8 pp-2277.8 pp
Peer median (excluding ABSI) -475.2%+257.7 pp-285.6 pp

Competitors are the stored peer set for ABSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.78M5.75M5.72M4.53M2.8M
Cost of Revenue44.59M58.91M47.57M62.46M11.74M
Gross Profit(39.8M)(53.16M)(41.85M)(57.93M)(8.94M)
Gross Margin-832.4%-925.0%-731.9%-1277.6%-319.4%
Research & Development44.59M58.91M48.07M63.86M81.42M
Selling, General & Admin000035.06M
Operating Expenses35.43M53.59M73.67M50.96M115.78M
Depreciation & Amortization6.65M13.04M14M13.39M11.74M
EBITDA(67.68M)(91.36M)(79.68M)(94.1M)(103.16M)
EBITDA Margin-1415.4%-1589.6%-1393.5%-2075.4%-3684.4%
Operating Income(75.24M)(106.75M)(115.52M)(108.89M)(124.72M)
Operating Margin-1573.4%-1857.5%-2020.2%-2401.6%-4454.2%
Interest Income00000
Interest Expense3.43M972K1.01M565K209K
Other Income / Expenses(34.62M)1.39M5.05M5.85M9.6M
Income Before Tax(109.86M)(105.37M)(110.47M)(103.04M)(115.11M)
Pre-Tax Margin-2297.3%-1833.4%-1931.9%-2272.5%-4111.2%
Income Tax Expense(8.9M)(461K)100K70K69K
Net Income(100.96M)(104.9M)(110.57M)(103.11M)(115.18M)
Net Margin-2111.3%-1825.4%-1933.6%-2274.1%-4113.7%
EPS (Basic)(1.11)(1.15)(1.20)(0.94)(0.84)
EPS (Diluted)(1.11)(1.15)(1.20)(0.94)(0.84)
Weighted Avg Shares92.65M90.85M92.03M110.24M136.78M
Weighted Avg Shares (Diluted)92.65M90.85M92.03M110.24M136.78M

Absci Corporation

NASDAQ:ABSI

Intrinsic Alpha fair value

Locked

Current Price

$8.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.